Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:527-532
doi: 10.1161/hc3001.093503
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hernandez-Pampaloni, M.
Right arrow Articles by Schelbert, H. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hernandez-Pampaloni, M.
Right arrow Articles by Schelbert, H. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Nuclear cardiology and PET
Right arrow Coronary circulation

(Circulation. 2001;104:527.)
© 2001 American Heart Association, Inc.


Clinical Investigation and Reports

Abnormal Longitudinal, Base-to-Apex Myocardial Perfusion Gradient by Quantitative Blood Flow Measurements in Patients With Coronary Risk Factors

Miguel Hernandez-Pampaloni, MD, PhD; Felix Y.J. Keng, MD; Takashi Kudo, MD, PhD; James S. Sayre, PhD; Heinrich R. Schelbert, MD, PhD

From the Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, Calif.

Correspondence to Heinrich R. Schelbert, MD, PhD, Department of Molecular and Medical Pharmacology, UCLA School of Medicine, 10833 Leconte Ave, 23-120 CHS, Box 173517, Los Angeles, CA 90095-1735. E-mail hschelbert{at}mednet.ucla.edu

Background— A longitudinal, base-to-apex myocardial perfusion gradient has been described in patients with coronary artery disease (CAD) and was attributed to diffuse coronary luminal narrowing. We asked whether an abnormal perfusion gradient also existed in patients without CAD but with coronary risk factors. We measured myocardial blood flow (MBF) with 13N-ammonia and PET at rest and during hyperemia in patients with coronary risk factors but without CAD.

Methods and Results— Regional MBF was measured in absolute units with 13N-ammonia and PET at rest and during dipyridamole hyperemia in 36 patients with coronary risk factors (age, 55±10 years) and in 36 age-matched (age, 53±10 years) and in 28 young (age, 25±5 years) normal subjects. MBF was determined globally, for each of the 3 coronary territories, and in the mid and mid-to-apical sections of the left ventricle (LV). Myocardial perfusion on qualitative analysis was normal at rest and during hyperemia, and no flow defects were present. MBF in absolute units was similar in the 3 coronary territories. However, hyperemic MBFs in the mid-to-apical LV section were lower than in the mid LV section in the "at-risk" group (2.04±0.61 versus 1.71±0.40 mL · min-1 · g-1; P<0.004) but not in the age-matched or in the young normal subjects.

Conclusions— The abnormal longitudinal, base-to-apex perfusion gradient observed during dipyridamole MBF suggests the presence of a functional and/or structural alteration of the coronary circulation associated with coronary risk factors, possibly reflecting developing coronary atherosclerosis or preclinical CAD.


Key Words: blood flow • circulation • tomography • risk factors




This article has been cited by other articles:


Home page
CirculationHome page
M. F. Di Carli and R. Hachamovitch
New Technology for Noninvasive Evaluation of Coronary Artery Disease
Circulation, March 20, 2007; 115(11): 1464 - 1480.
[Full Text] [PDF]


Home page
JNMHome page
D. S. Berman, R. Hachamovitch, L. J. Shaw, J. D. Friedman, S. W. Hayes, L. E.J. Thomson, D. S. Fieno, G. Germano, N. D. Wong, X. Kang, et al.
Roles of Nuclear Cardiology, Cardiac Computed Tomography, and Cardiac Magnetic Resonance: Noninvasive Risk Stratification and a Conceptual Framework for the Selection of Noninvasive Imaging Tests in Patients with Known or Suspected Coronary Artery Disease
J. Nucl. Med., July 1, 2006; 47(7): 1107 - 1118.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. K. Mishra, S. Dorbala, G. Logsetty, A. Hassan, T. Heinonen, H. R. Schelbert, M. F. Di Carli, and RAMPART Investigators
Quantitative relation between hemodynamic changes during intravenous adenosine infusion and the magnitude of coronary hyperemia: Implications for myocardial perfusion imaging
J. Am. Coll. Cardiol., February 15, 2005; 45(4): 553 - 558.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
I. S. Wittstein, D. R. Thiemann, J. A.C. Lima, K. L. Baughman, S. P. Schulman, G. Gerstenblith, K. C. Wu, J. J. Rade, T. J. Bivalacqua, and H. C. Champion
Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress
N. Engl. J. Med., February 10, 2005; 352(6): 539 - 548.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. H. Schindler, E. U. Nitzsche, M. Olschewski, N. Magosaki, M. Mix, J. O. Prior, A. D. Facta, U. Solzbach, H. Just, and H. R. Schelbert
Chronic Inflammation and Impaired Coronary Vasoreactivity in Patients With Coronary Risk Factors
Circulation, August 31, 2004; 110(9): 1069 - 1075.
[Abstract] [Full Text] [PDF]